Mira Pharmaceuticals earnings were -$7.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MIRA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.4M, up 17.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MIRA reported annual earnings of -$7.9M, with -34.5% growth.
Mira Pharmaceuticals Earnings Reports & History FAQ
What were Mira Pharmaceuticals's earnings last quarter?
Mira Pharmaceuticals (NASDAQ: MIRA) reported Q4 2024 earnings per share (EPS) of -$0.15, up 62.5% year over year. Total MIRA earnings for the quarter were -$2.40 million. In the same quarter last year, Mira Pharmaceuticals's earnings per share (EPS) was -$0.40.
Is Mira Pharmaceuticals profitable or losing money?
As of the last Mira Pharmaceuticals earnings report, Mira Pharmaceuticals is currently losing money. Mira Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$7.85 million, a 34.46% decrease year over year.
What was MIRA's earnings growth in the past year?
As of Mira Pharmaceuticals's earnings date in Q2 2025, Mira Pharmaceuticals's earnings has grown year over year. MIRA earnings in the past year totalled -$7.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.